IMPROVED RETROVIRAL TRANSDUCTION EFFICIENCY OF VASCULAR CELLS IN-VITRO AND IN-VIVO DURING CLINICALLY RELEVANT INCUBATION PERIODS USING CENTRIFUGATION TO INCREASE VIRAL TITERS
Ja. Zelenock et al., IMPROVED RETROVIRAL TRANSDUCTION EFFICIENCY OF VASCULAR CELLS IN-VITRO AND IN-VIVO DURING CLINICALLY RELEVANT INCUBATION PERIODS USING CENTRIFUGATION TO INCREASE VIRAL TITERS, Journal of vascular surgery, 26(1), 1997, pp. 119-127
Vascular cells are an important target for gene transfer because of th
eir potential to deliver gene products both locally and systemically.
Direct retroviral gene transfer to vascular cells in vivo has been lim
ited by inefficient rates of transduction. We hypothesized that vascul
ar cell transduction efficiency (TE), during shea retroviral incubatio
n periods, is significantly improved in vitro and in vivo using centri
fugation to increase viral titer. Furthermore, we hypothesized a linea
r relationship between concentration of viable viral particles (measur
ed as colony-forming units (CFUs)/cell) and retroviral TE during short
incubation periods. Cultured rat pulmonary artery endothelial cells (
RPAECs), rat aortic smooth muscle cells (RSMCs), and human iliac arter
y endothelial cells (HIAECs) demonstrated a strong correlation between
TE and high concentrations of virus (>100 CFU/cell) during retroviral
incubation periods of 10 to 60 minutes. High titers, and thereby high
concentrations, were achieved by centrifugation and resuspension in a
fraction of the original volume. Titer was consistently increased ten
fold, for a twentyfold increase in concentration by volume. A 20-minut
e incubation with a Moloney murine leukemia-derived retroviral vector
coding for human placental alkaline phosphatase, pLJhpAP, at a concent
ration of 1150 CFU/cell yielded TEs of 10.6% +/- 0.7%, 40.4% +/- 1.6%,
and 15.1% +/- 2.0% for RPAECs, RSMCs, and HIAECs, respectively. A sim
ilar effect was shown using the Moloney murine leukemia-derived MFGlac
Z retroviral vector, coding for Escherichia coli beta-galactosidase. I
ncreased titer and concentration had no effect on target cell viabilit
y, as shown by trypan blue exclusion. Although RSMCs had the most cell
s transduced in a given incubation period (p < 0.05), RPAECs had the h
ighest replication rate (p < 0.05), suggesting the importance of facto
rs other than cell cycle on retroviral TEs during short, clinically re
levant incubation periods. In subsequent in vivo experiments, gene tra
nsfer was achieved in the rat carotid artery during a 20-minute incuba
tion period infusing the concentrated pLJhpAP retrovirus after carotid
balloon injury. Rats infused with virus 2 days after balloon injury e
xhibited hpAP activity (0 to 10 cells/section/rat) in the neointima of
five out of six rats. Rats infused 4 days after balloon injury exhibi
ted hpAP activity (0 to 25 cells/section/rat) in the media and adventi
tia of five out of five rats. Control rats that received the balloon i
njury alone or the balloon injury and unconcentrated retrovirus exhibi
ted zero hpAP activity. We conclude that the TE of retroviral-mediated
gene transfer to vascular cells in vitro and in vivo can be improved
during short, clinically relevant incubation periods using centrifugat
ion to increase retroviral titer, and thereby concentration of viable
viral particles.